370 related articles for article (PubMed ID: 10759686)
1. Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes.
Rawden HC; Kokwaro GO; Ward SA; Edwards G
Br J Clin Pharmacol; 2000 Apr; 49(4):313-22. PubMed ID: 10759686
[TBL] [Abstract][Full Text] [Related]
2. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
Kousba A; Soll R; Yee S; Martin M
Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660
[TBL] [Abstract][Full Text] [Related]
3. Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes and the inhibitory effect of methimazole.
Lanusse CE; Nare B; Prichard RK
Xenobiotica; 1993 Mar; 23(3):285-95. PubMed ID: 8498091
[TBL] [Abstract][Full Text] [Related]
4. Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes.
el Amri HS; Fargetton X; Delatour P; Batt AM
Xenobiotica; 1987 Oct; 17(10):1159-68. PubMed ID: 3424864
[TBL] [Abstract][Full Text] [Related]
5. Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle.
Virkel G; Lifschitz A; Sallovitz J; Pis A; Lanusse C
Drug Metab Dispos; 2004 May; 32(5):536-44. PubMed ID: 15100176
[TBL] [Abstract][Full Text] [Related]
6. Small intestinal sulphoxidation of albendazole.
Villaverde C; Alvarez AI; Redondo P; Voces J; Del Estal JL; Prieto JG
Xenobiotica; 1995 May; 25(5):433-41. PubMed ID: 7571717
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
8. Identification of the major human liver cytochrome P450 isoform(s) responsible for the formation of the primary metabolites of ziprasidone and prediction of possible drug interactions.
Prakash C; Kamel A; Cui D; Whalen RD; Miceli JJ; Tweedie D
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):35S-42S. PubMed ID: 10771452
[TBL] [Abstract][Full Text] [Related]
9. Liver sulphoxidative metabolism of albendazole in rat: enantioselectivity and effect of methimazole.
Solana HD; Sallovitz JM; Najle R; Rodriguez JA; Lanusse CE
Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):83-8. PubMed ID: 10849890
[TBL] [Abstract][Full Text] [Related]
10. CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.
Wu Z; Lee D; Joo J; Shin JH; Kang W; Oh S; Lee DY; Lee SJ; Yea SS; Lee HS; Lee T; Liu KH
Antimicrob Agents Chemother; 2013 Nov; 57(11):5448-56. PubMed ID: 23959307
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective liver microsomal sulphoxidation of albendazole in cattle: effect of nutritional status.
Virkel G; Lifschitz A; Soraci A; Sansinanea A; Lanusse C
Xenobiotica; 2000 Apr; 30(4):381-93. PubMed ID: 10821167
[TBL] [Abstract][Full Text] [Related]
12. The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s.
Potega A; Dabrowska E; Niemira M; Kot-Wasik A; Ronseaux S; Henderson CJ; Wolf CR; Mazerska Z
Drug Metab Dispos; 2011 Aug; 39(8):1423-32. PubMed ID: 21555506
[TBL] [Abstract][Full Text] [Related]
13. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5.
Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R
J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214
[TBL] [Abstract][Full Text] [Related]
14. Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.
Moroni P; Buronfosse T; Longin-Sauvageon C; Delatour P; Benoit E
Drug Metab Dispos; 1995 Feb; 23(2):160-5. PubMed ID: 7736906
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cytochrome P450 and the flavin-containing monooxygenase(s) in the sulphoxidation of simple sulphides in human liver microsomes.
Nnane IP; Damani LA
Life Sci; 2003 Jun; 73(3):359-69. PubMed ID: 12757843
[TBL] [Abstract][Full Text] [Related]
16. Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes.
Shiraga T; Kaneko H; Iwasaki K; Tozuka Z; Suzuki A; Hata T
Xenobiotica; 1999 Mar; 29(3):217-29. PubMed ID: 10219963
[TBL] [Abstract][Full Text] [Related]
17. A convenient method to discriminate between cytochrome P450 enzymes and flavin-containing monooxygenases in human liver microsomes.
Grothusen A; Hardt J; Bräutigam L; Lang D; Böcker R
Arch Toxicol; 1996; 71(1-2):64-71. PubMed ID: 9010587
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
Bournique B; Lambert N; Boukaiba R; Martinet M
Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
[TBL] [Abstract][Full Text] [Related]
19. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
20. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
